Diagnostics
FDG-PET purported as useful imaging modality for restaging of ovarian cancer
Published in Cancer Weekly, November 8th, 2005
"FDG-PET, which originated as a research tool to evaluate glucose metabolism in cancer tissues, has now become an essential imaging modality for determining the appropriate therapeutic management of various cancer patients. The clinical role of FDG-PET for gynecologic tumors has not been established yet, but FDG-PET has come to be considered one of the important imaging modalities for evaluating patients with gynecological cancers," scientists reported in the International Journal of Gynecological...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-11-08)
More Articles from Cancer Weekly
- Cancer Risk Factors
Patients with rheumatoid arthritis linked to increased risk of cancer - Diagnostics
Modern imaging modalities used to assess resectability of pancreatic cancer - Glioma
PARP inhibition may increase temozolomide efficacy in treatment of malignant gliomas - Prognostics
Treatment efficacy indicated by incidence of chemotherapy-induced neutropenia - Adjuvant Chemotherapy
Colorectal cancer adjuvant treatment in elderly patients discussed - Adverse Drug Reaction
Case study suggests hydroxyurea therapy may be implicated in neuroendocrine carcinoma - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
